Modules
Bellwood Clinical Group, Corp.
Customer 7918
- Account Classification
- Unknown
- Classification Confidence
- Medium
- Sites
- Vendor
- Assigned Reps
- Priya Sandoval
- Website
- —
- Active Opportunity Count
- 5
- Published Count
- 0
- Revenue Base
- 0
- Known GPBase
- 0
- Analyzer Platforms
- MicroGenics
- Product Groups
- MicroGenics
- Recommended Contact
- Talia Brennock
- Backup Contact
- Ezra Xiong | Lab Supervisor | ezra.xiong@bellwoodclinicalgroupcorp.com | (330) 892-5191
- Last Meaningful Activity
- —
- Customer Memory
- AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is MicroGenics. Verified item fact: storage requirement N/A. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is MicroGenics. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-ef5131a2d3bf7cc4d9985a5b73e69a73e697fa3303ae10b99f8b04f89ddb616b | Customer 7918 | Candidate CAND-2255f151874ae8071862184788122b1feb327b5562f1d440a746c6b32ee3268e | Customer 7918 | Order 51015 | Item 13160 | Candidate CAND-6e7fb75692d436eb13e03348a6e8b07247fb9dba2a19ac82fff77a52ea377115 | Customer 7918 | Order 50830 | Item 12744 | Candidate CAND-1ac7ff3a528f4c19445ed23603816f189ee8c63ef39b07b623240c2291537041 | Customer 7918 | Order 50985 | Item 11509 | Candidate CAND-1a95e723f94014e5df11b07cb765c5590abfef0e4ab0830e78b8b421f41d3b8b | Customer 7918 | Order 50985 | Item 11555
Opportunities (10)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ef5131a2d3bf7cc4d9985a5b73e69a73e697fa3303ae10b99f8b04f89ddb616b | OPP-3bc6d1e73aa671af7ebda7383a507aaab2ddd67fa3e64c2f96c975f87e12624a | SER-8f16eea370409d747c558fc4312ee190c164529876a3954c44a5d55cc0109ed3 | Needs Validation | **** | **** | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | Columbiana | OH | Midwest | Unknown | Medium | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 6 independent signals; trailing 90-day revenue $0.00 versus $11844.24; trailing 180-day revenue $11844.24 versus $41784.22; 130 days beyond expected account order date. | 7484.99 | 14969.99 | 22454.98 | 2072.4 | 4144.81 | 6217.21 | 93.69 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-ef5131a2d3bf7cc4d9985a5b73e69a73e697fa3303ae10b99f8b04f89ddb616b | Customer 7918 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2255f151874ae8071862184788122b1feb327b5562f1d440a746c6b32ee3268e | OPP-a5dd4e9c91e454765198b43421c862eae7e88ad7b8c4d877b198c0c2b12f048d | SER-dcd2ff329c36c7538602f6931d2022571ef107f364c7e667544e016529da4848 | Needs Validation | **** | **** | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | Columbiana | OH | Midwest | Unknown | Medium | MicroGenics | MicroGenics | 986000 | 986000 Thermo Scientific INDIKO CUVETTES 10800/PK | — | 51015 | 11 completed purchases over 924 days; median interval 90.0 days; expected reorder 2026-06-12; High Risk by 59 days. | 1497.5 | 1996.67 | 2495.83 | 639.78 | 853.04 | 1066.3 | 83.79 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-2255f151874ae8071862184788122b1feb327b5562f1d440a746c6b32ee3268e | Customer 7918 | Order 51015 | Item 13160 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6e7fb75692d436eb13e03348a6e8b07247fb9dba2a19ac82fff77a52ea377115 | OPP-88857b4c02d5b6717aa4133a92d3af2dfd9bb863ae8b2f09ca00473a43786081 | SER-481ec3e6267055b901e340e5351d3a3ba3f51c02d2e941305125ef294a93178a | Needs Validation | **** | **** | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | Columbiana | OH | Midwest | Unknown | Medium | MicroGenics | MicroGenics | T-10020849 | Thermo Buprenorphine II Rgt CEDIA | — | 50830 | 23 completed purchases over 910 days; median interval 31.5 days; expected reorder 2026-04-15; High Risk by 117 days. | 1204.73 | 1606.31 | 2007.89 | 206.53 | 275.37 | 344.21 | 80.25 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-6e7fb75692d436eb13e03348a6e8b07247fb9dba2a19ac82fff77a52ea377115 | Customer 7918 | Order 50830 | Item 12744 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1ac7ff3a528f4c19445ed23603816f189ee8c63ef39b07b623240c2291537041 | OPP-e606f660fdc0a14435f639d9793843ee534d06e080582a0a5a98d1482e7c83ff | SER-644dc52621e65c4c224d341a3dee6666a5e6cbb6dc22f6f892030fd890cacb7d | Needs Validation | **** | **** | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | Columbiana | OH | Midwest | Unknown | Medium | MicroGenics | MicroGenics | T-10014593 | Thermo Kit Cocaine Rgt DRI | — | 50985 | 31 completed purchases over 922 days; median interval 27.0 days; expected reorder 2026-04-07; High Risk by 125 days. | 227.87 | 303.83 | 379.79 | 50.35 | 67.13 | 83.91 | 72.89 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-1ac7ff3a528f4c19445ed23603816f189ee8c63ef39b07b623240c2291537041 | Customer 7918 | Order 50985 | Item 11509 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1a95e723f94014e5df11b07cb765c5590abfef0e4ab0830e78b8b421f41d3b8b | OPP-db77922290355a28edd1234c416c15451834335d3c1b3ea6c227b12dd860ab83 | SER-1ac8d7ff1e4943110b2d3e58ba9ba948127bced402029f40ba77662788e15a87 | Needs Validation | **** | **** | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | Columbiana | OH | Midwest | Unknown | Medium | MicroGenics | MicroGenics | T-10016403 | Thermo Kit Methadone Rgt DRI | — | 50985 | 33 completed purchases over 922 days; median interval 26.0 days; expected reorder 2026-04-06; High Risk by 126 days. | 187.21 | 249.61 | 312.01 | 49.36 | 65.81 | 82.26 | 72.41 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-1a95e723f94014e5df11b07cb765c5590abfef0e4ab0830e78b8b421f41d3b8b | Customer 7918 | Order 50985 | Item 11555 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ef5131a2d3bf7cc4d9985a5b73e69a73e697fa3303ae10b99f8b04f89ddb616b | OPP-3bc6d1e73aa671af7ebda7383a507aaab2ddd67fa3e64c2f96c975f87e12624a | SER-8f16eea370409d747c558fc4312ee190c164529876a3954c44a5d55cc0109ed3 | — | **** | — | — | Bellwood Clinical Group, Corp. | 7918 | Vendor | — | OH | — | — | — | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 6 independent signals; trailing 90-day revenue $0.00 versus $11844.24; trailing 180-day revenue $11844.24 versus $41784.22; 130 days beyond expected account order date. | — | 14969.99 | — | — | 4144.81 | — | 93.69 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-ef5131a2d3bf7cc4d9985a5b73e69a73e697fa3303ae10b99f8b04f89ddb616b | Customer 7918 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2255f151874ae8071862184788122b1feb327b5562f1d440a746c6b32ee3268e | OPP-a5dd4e9c91e454765198b43421c862eae7e88ad7b8c4d877b198c0c2b12f048d | SER-dcd2ff329c36c7538602f6931d2022571ef107f364c7e667544e016529da4848 | — | **** | — | — | Bellwood Clinical Group, Corp. | 7918 | Vendor | — | OH | — | — | — | MicroGenics | — | — | — | — | — | 11 completed purchases over 924 days; median interval 90.0 days; expected reorder 2026-06-12; High Risk by 59 days. | — | 1996.67 | — | — | 853.04 | — | 83.79 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-2255f151874ae8071862184788122b1feb327b5562f1d440a746c6b32ee3268e | Customer 7918 | Order 51015 | Item 13160 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6e7fb75692d436eb13e03348a6e8b07247fb9dba2a19ac82fff77a52ea377115 | OPP-88857b4c02d5b6717aa4133a92d3af2dfd9bb863ae8b2f09ca00473a43786081 | SER-481ec3e6267055b901e340e5351d3a3ba3f51c02d2e941305125ef294a93178a | — | **** | — | — | Bellwood Clinical Group, Corp. | 7918 | Vendor | — | OH | — | — | — | MicroGenics | — | — | — | — | — | 23 completed purchases over 910 days; median interval 31.5 days; expected reorder 2026-04-15; High Risk by 117 days. | — | 1606.31 | — | — | 275.37 | — | 80.25 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-6e7fb75692d436eb13e03348a6e8b07247fb9dba2a19ac82fff77a52ea377115 | Customer 7918 | Order 50830 | Item 12744 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1ac7ff3a528f4c19445ed23603816f189ee8c63ef39b07b623240c2291537041 | OPP-e606f660fdc0a14435f639d9793843ee534d06e080582a0a5a98d1482e7c83ff | SER-644dc52621e65c4c224d341a3dee6666a5e6cbb6dc22f6f892030fd890cacb7d | — | **** | — | — | Bellwood Clinical Group, Corp. | 7918 | Vendor | — | OH | — | — | — | MicroGenics | — | — | — | — | — | 31 completed purchases over 922 days; median interval 27.0 days; expected reorder 2026-04-07; High Risk by 125 days. | — | 303.83 | — | — | 67.13 | — | 72.89 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-1ac7ff3a528f4c19445ed23603816f189ee8c63ef39b07b623240c2291537041 | Customer 7918 | Order 50985 | Item 11509 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1a95e723f94014e5df11b07cb765c5590abfef0e4ab0830e78b8b421f41d3b8b | OPP-db77922290355a28edd1234c416c15451834335d3c1b3ea6c227b12dd860ab83 | SER-1ac8d7ff1e4943110b2d3e58ba9ba948127bced402029f40ba77662788e15a87 | — | **** | — | — | Bellwood Clinical Group, Corp. | 7918 | Vendor | — | OH | — | — | — | MicroGenics | — | — | — | — | — | 33 completed purchases over 922 days; median interval 26.0 days; expected reorder 2026-04-06; High Risk by 126 days. | — | 249.61 | — | — | 65.81 | — | 72.41 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-1a95e723f94014e5df11b07cb765c5590abfef0e4ab0830e78b8b421f41d3b8b | Customer 7918 | Order 50985 | Item 11555 |